Table 1.
1 | Age |
2 | Gender |
3 | Obesity (BMI >30 kgm−2) |
4 | Personal history of VTE – confirmed previous VTE event >6 months prior |
5 | Family history of VTE – confirmed VTE in parents or siblings |
6 | Active malignancy |
7 | Medical risk factors: |
• General acute or chronic medical immobility for greater than >2 days duration, other than postoperatively. Includes bed rest, overdose with reduced level of consciousness, or wheelchair use in the four weeks preceding the event | |
• Relevant chronic medical illness known to predispose to VTE, such as inflammatory bowel disease, cardiomyopathy/congestive heart failure, connective tissue disease including inflammatory arthritis | |
8 | Hormonal: |
• Hormone therapy – hormonal contraceptive or hormone replacement therapy or hormonal antagonist therapy for malignancy | |
• Pregnancy | |
9 | Surgery: |
• Surgery – requiring general anaesthetic or spinal/epidural anaesthesia in the four weeks preceding the event | |
10 | Trauma or cast immobility: |
• Trauma – requiring medical attention | |
• Cast immobility – orthopaedic limb/foot cast in the 4 weeks preceding the event | |
11 | International air travel: |
• International air travel in the four weeks preceding the event* | |
12 | Prolonged seated immobility: the duration seated at work and at home seated at a computer, in the four weeks preceding the event, defined as: |
• seated at least 10 hours in a 24 hour period and at least 2 hours at a time without getting up |
International air travel beyond New Zealand involves air flight of ≥3.5 hours